DeepChek® Assay 16S rRNA BACTERIAL IDENTIFICATION

End-to-end RUO Solution for Mycobacterium Tuberculosis Drug Susceptibility Testing by Sequencing Suited to Small, Medium & High Throughput Laboratories

Description

The DeepChek® Assay 13-Plex KB Drug Susceptibility Testing V1 allow you to target the most relevant 13 genes and study their associated drug resistance with BacterioChek®-TB software.  

1st Line

2nd Line

3rd Line

Features

▪ Multiplex in one single tube

▪13 genes targeted

▪ Heteroresistance: Down to 0.1%
▪ Sensitivity < 1000 cp/mL (optimization ongoing)
▪ Validated on various Liquid & Solid Cultures

▪ Validated on iSeq100, MiniSeq, MiSeq (Illumina)
▪ Validated on S5 + Ion Chef (ThermoFisher)
▪ Validation on NanoPore MinIon ongoing

Example of Reports

Ordering Information

Product Reference
DeepChek® Assay 13-Plex KB DRUG SUSCEPTIBILITY TESTING V1 (RUO)
128A24
BacterioChek® - TB Software (CE-IVD)
S-12-023 (TL)

Downloads

Leaflet

Quick Links:

Find us on:

ABL France SAS (ABL SA Group)
5, Bd de Trèves
F-57070 Metz, France

Scroll to Top